Immune System Tricked In Diabetic MiceThe body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it. This is the problem when people with type 1 diabetes undergo human islet cell transplantation. The islet cells from a donor pancreas produce robust amounts of insulin for the recipient -- often permitting independence from insulin therapy. However, the immune system tries to kill the new hard-working islets.
Steering Diabetes Patients Through The Sweetest SeasonNovember ushers in American Diabetes Month not only a time to be thankful for bustling basic and clinical research underway on the disease, but also the unofficial start of the holiday season. Between now and New Year's, people with diabetes must navigate a tempting course of sugar-centric festivities, maintaining a delicate nutritional balance against all odds. "It's possible," said Nicholas Jospe, M.D.
Researchers At IRB Barcelona Produce More Data On Key Genes In DiabetesOne of the most reliable indicators to predict that a person will develop type 2 diabetes is the presence of insulin resistance. Insulin is produced in the pancreas and is the hormone responsible for ensuring that glucose reaches several tissues and organs in the body, such as muscles. Insulin resistance is characterized by the lack of tissue response to insulin and is counteracted by a greater production of insulin by the pancreas.
Successfull Completion Of Phase I Development Of In Vivo Glucose Sensing RFID MicrochipVeriChip Corporation ("VeriChip") (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that a significant milestone has been achieved toward the development of an in vivo glucose-sensing RFID microchip.
News From The American Chemical Society, Nov. 19, 2008Microcapsules act as "roach motel" to kill harmful bacteria Researchers in New Mexico and Florida are reporting development of microscopic particles that act as chemical booby traps for bacteria. The traps attract and kill up to 95 percent of nearby bacteria, including microbes responsible for worrisome hospital-based infections. The scientists describe their discovery as micro-sized "roach motels" for harmful bacteria.
Diabetes I And II In Mouse Model Treated By Garlic Chemical TabletA drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says. When Hiromu Sakurai and colleagues from the Suzuka University of Medical Science, Japan, gave the drug orally to type I diabetic mice, they found it reduced blood glucose levels.
Physicians Should Closely Monitor Elderly Patients With Kidney Damage And Look For Signs Of Organ FailureAcute kidney injury (AKI) - which is often caused by trauma, illness, or surgery - predisposes elderly individuals to the most serious form of chronic kidney disease (CKD), known as end stage renal disease (ESRD), according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). The findings indicate that close medical follow-up is important for maintaining the health of patients who have experienced kidney damage.
New Study Highlights Rising Number Of Type 2 Diabetes Patients In U.S., Increasing Complexity Of TreatmentsAn increasing number of type 2 diabetes patients in the U.S. are being treated by a progressively complex mix of therapies, according to a study featured in Archives of Internal Medicine, a JAMA/Archives journal. The report is the first to be published by members of the Health Services Research Network (HSRN), a consortium of leading U.S. academicians that conducts independent research using IMS Health's evidence-based information to address key healthcare issues.
Joint Biomarker Research Related To Insulin Resistance And Diabetes - Metabolon And Joslin Diabetes CenterMetabolon, Inc., the leader in metabolomics-driven biomarker discovery and development, and the Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, today announced a collaboration to carry out human clinical and animal studies in the area of insulin resistance and type 2 diabetes. This collaboration agreement includes a series of studies to be conducted using Metabolon's biochemical profiling technology.
Rise In Diabetes Among American Indian Youth Focus Of New National Education Program For Tribal SchoolsTo address the growing epidemic of type 2 diabetes affecting American Indian youth, researchers from UNLV were part of a national collaboration with three federal agencies and eight tribal colleges to develop "Health is Life in Balance" - an innovative K-12 diabetes curriculum for tribal schools and schools with large American Indian/Alaska Native populations. The curriculum blends the science of diabetes with Native cultural teachings.
Genetic Testing For Diabetes Type 2 Still In Its InfancyGenetic testing for type 2 diabetes is still in its infancy, said researchers who did a US study that compared risk assessment based on screening for gene variants with more traditional risk factors like weight, blood pressure and blood sugar.
Diabetes Cost U.S. $218B In 2007, Report Finds Diabetes in 2007 cost the U.S. $218 billion in direct medical care and indirect costs, such as lost productivity, according to a report released on Tuesday, the AP/Raleigh News & Observer reports. For the report -- funded by Novo Nordisk, which manufactures insulin and diabetes medications -- researchers at the
![](\"http://www.igotyourindex.com/igyindex.gif?DOCUMENTNAME=&DOCUMENTLINK=&GOALNAME&=DOCUMENTVALUE&=GROUPNAME\")